HCP
ELV icon

Hexagon Capital Partners’s Elevance Health ELV Stock Holding History

Hexagon Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-61
Closed -$26.5K – 543
2025
Q1 		$26.5K Buy
61
+18
+42% +$7.23K 0.01% 653
2024
Q4 		$15.9K Sell
43
-52
-55% -$21.8K ﹤0.01% 873
2024
Q3 		$49.4K Buy
95
+30
+46% +$16K 0.01% 457
2024
Q2 		$35.2K Buy
65
+1
+2% +$529 0.01% 516
2024
Q1 		$33.2K Sell
64
-11
-15% -$5.47K 0.01% 527
2023
Q4 		$35.4K Buy
75
+29
+63% +$13.4K 0.01% 490
2023
Q3 		$20K Buy
46
+10
+28% +$4.54K 0.01% 550
2023
Q2 		$16K Buy
36
+3
+9% +$1.38K ﹤0.01% 617
2023
Q1 		$15.2K Sell
33
-18
-35% -$8.57K ﹤0.01% 625
2022
Q4 		$26.2K Sell
51
-21
-29% -$10.7K 0.01% 481
2022
Q3 		$33K Buy
72
+67
+1,340% +$32.1K 0.01% 477
2022
Q2 		$2K Buy
5
+4
+400% +$1.98K ﹤0.01% 955
2022
Q1 		$0 Buy
+1
New +$457 ﹤0.01% 934

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Hexagon Capital Partners's ELV Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 61 shares — an estimated $26.5K sold.

Hexagon Capital Partners first reported a position in ELV in Q1 2022 and held it in 13 quarters. The position peaked at $49.4K in Q3 2024. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 61 Elevance Health shares in Q2 2025, an estimated $26.5K.
  • Hexagon Capital Partners first reported a position in Elevance Health in Q1 2022 and held it in 13 quarters.
  • Hexagon Capital Partners's Elevance Health position peaked at $49.4K in Q3 2024.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.